Spots Global Cancer Trial Database for autologous tumor cell vaccine
Every month we try and update this database with for autologous tumor cell vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma | NCT00020462 | Lymphoma | aldesleukin autologous tumo... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | NCT01339663 | Recurrent Melan... Stage IV Melano... | cyclophosphamid... aldesleukin autologous tumo... laboratory biom... immunologic tec... immunohistochem... polymerase chai... therapeutic aut... | 18 Years - | Fred Hutchinson Cancer Center | |
| DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | NCT00085436 | Kidney Cancer | Aldesleukin, autologous tumo... recombinant int... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma | NCT00004022 | Melanoma (Skin) | aldesleukin autologous tumo... muromonab-CD3 therapeutic aut... surgical proced... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia | NCT00100971 | Leukemia | autologous tumo... therapeutic aut... tumor cell-deri... | 18 Years - | Boston Medical Center | |
| Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | NCT00436930 | Melanoma (Skin) | autologous tumo... sargramostim therapeutic aut... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma | NCT00003715 | Melanoma (Skin) | BCG vaccine autologous tumo... recombinant int... chemotherapy cyclophosphamid... | 18 Years - 120 Years | AVAX Technologies | |
| Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant | NCT00469820 | Leukemia Multiple Myelom... | autologous tumo... peripheral bloo... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | NCT00093522 | Kidney Cancer | autologous tumo... keyhole limpet ... therapeutic aut... fludarabine pho... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma | NCT00006478 | Lymphoma | autologous tumo... keyhole limpet ... sargramostim adjuvant therap... | 19 Years - | University of Nebraska | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | NCT01339663 | Recurrent Melan... Stage IV Melano... | cyclophosphamid... aldesleukin autologous tumo... laboratory biom... immunologic tec... immunohistochem... polymerase chai... therapeutic aut... | 18 Years - | Fred Hutchinson Cancer Center | |
| Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx | NCT00002454 | Precancerous Co... | autologous tumo... | 1 Year - | National Cancer Institute (NCI) | |
| Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma | NCT00004024 | Brain and Centr... | aldesleukin autologous tumo... muromonab-CD3 sargramostim therapeutic aut... surgical proced... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | NCT00085436 | Kidney Cancer | Aldesleukin, autologous tumo... recombinant int... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma | NCT00004022 | Melanoma (Skin) | aldesleukin autologous tumo... muromonab-CD3 therapeutic aut... surgical proced... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00023985 | Lung Cancer | autologous tumo... therapeutic aut... conventional su... | 18 Years - 75 Years | Roswell Park Cancer Institute | |
| Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer | NCT00014573 | Brain and Centr... | aldesleukin autologous tumo... filgrastim sargramostim therapeutic aut... carmustine cisplatin cyclophosphamid... paclitaxel autologous bone... conventional su... peripheral bloo... | - 65 Years | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma | NCT00126685 | Melanoma (Skin) | autologous tumo... therapeutic aut... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells | NCT00948480 | Metastatic Mela... | Autologous tumo... GM-CSF | 16 Years - | Hoag Memorial Hospital Presbyterian | |
| Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | NCT00093522 | Kidney Cancer | autologous tumo... keyhole limpet ... therapeutic aut... fludarabine pho... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx | NCT00002454 | Precancerous Co... | autologous tumo... | 1 Year - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00085488 | Melanoma (Skin) | autologous tumo... therapeutic aut... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| A Trial of FANG™ Vaccine for Participants With Ovarian Cancer | NCT01309230 | Ovarian Cancer | Vigil™ | 18 Years - | Gradalis, Inc. | |
| Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells | NCT00948480 | Metastatic Mela... | Autologous tumo... GM-CSF | 16 Years - | Hoag Memorial Hospital Presbyterian | |
| Biological Therapy in Treating Patients With Glioblastoma Multiforme | NCT00003185 | Brain and Centr... | autologous tumo... sargramostim tumor-draining ... cyclophosphamid... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
| Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia | NCT00343447 | Leukemia | autologous tumo... rituximab cyclophosphamid... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Biological Therapy in Treating Patients With Glioblastoma Multiforme | NCT00003185 | Brain and Centr... | autologous tumo... sargramostim tumor-draining ... cyclophosphamid... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00023985 | Lung Cancer | autologous tumo... therapeutic aut... conventional su... | 18 Years - 75 Years | Roswell Park Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
